Sulfinpyrazone

Back to search

Molecule Structure

Scientific Name

Sulfinpyrazone

Description of the Drug

Sulfinpyrazone is a platelet inhibitory and uricosuric agent used to inhibit thrombotic and embolic processes and to manage the chronic phases of gout .

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01138

Brand Name(s)

Anturan, Anturane, Sulfinpyrazone

Company Owner(s)

Watson Laboratories Inc, Par Pharmaceutical Inc, Vangard Laboratories Inc Div Midway Medical Co, Ivax Pharmaceuticals Inc, Barr Laboratories Inc, Novartis Pharmaceuticals Corp

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Solute carrier family 22 member 12 SINGLE PROTEIN INHIBITOR CHEMBL6120

Unichem Links

SureChEMBL SCHEMBL34421
PharmGKB PA451550
Human Metabolome Database HMDB0015269
DrugBank DB01138
PubChem: Thomson Pharma 14879380
PubChem 5342
Mcule MCULE-8521771467
LINCS LSM-1491
Nikkaji J1.384F
BindingDB 50237626
EPA CompTox Dashboard DTXSID0023618
DrugCentral 2528
Brenda 8421
ChemicalBook CB2122351
Guide to Pharmacology 5826
rxnorm SULFINPYRAZONE
KEGG Ligand C07317
ChEBI 9342